Vodafone Appoints E&'s Hatem Dowidar as Nonexecutive Director
By Najat Kantouar
Vodafone Group said that Emirates Telecommunications Group Company's Chief Executive Hatem Dowidar has now been appointed to the board as a nonexecutive director as part of its agreement announced in May.
The U.K.-based telecommunications company said Wednesday that Dowidar will join the board on Feb. 19.
On May 11, Vodafone and Emirates Telecommunications--known as E&--agreed to a strategic relationship that would see the latter become a cornerstone shareholder in the U.K. telecoms company.
As part of the agreement Dowidar was to join the Vodafone board as a nonexecutive director as long as E& maintains its shareholding of 14.6%, it said at the time. E& will also have the ability to nominate a second nonexecutive director if its shareholding exceeds 20%.
"He [Dowidar] brings extensive experience within the telecommunications industry and has held senior positions across a range of companies in the Middle East, Africa and Europe. His appointment will further strengthen our strategic partnership," Chair of Vodafone Jean-Francois van Boxmeer said.
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
February 14, 2024 02:47 ET (07:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year